ASS1 and central nervous system cancer: Miao et al. [31] demonstrated that METTL14 promotes glioma development by inhibiting the expression of argininosuccinate synthase 1 (ASS1) in an m6A-dependent manner and that high ASS1 expression can inhibit the proliferation, migration, invasion, and growth of glioma cells.